Talphera (TLPH) Total Liabilities (2010 - 2026)
Talphera (TLPH) posted quarterly Total Liabilities of $11.7 million for Q1 2026, up 24.28% year-over-year from $9.4 million in Q1 2025, and down 7.94% quarter-over-quarter from $12.7 million in Q4 2025.
Talphera (TLPH) Total Liabilities (2010 - 2026) Analysis & Trends
Talphera's Total Liabilities history runs 17 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 24.28% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $11.7 million (up 24.28% YoY), while the FY2025 annual figure was $12.7 million, up 23.93% from the prior year.
- Total Liabilities for Q1 2026 stood at $11.7 million, down from $12.7 million in the prior quarter.
- The five-year high for Total Liabilities was $110.2 million in Q1 2022, with the low at $5.0 million in Q3 2023.
- The 5-year median for Total Liabilities is $11.7 million (2026), against an average of $18.3 million.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities slumped 89.07% in 2023, then surged 129.57% in 2024.
- Talphera's Total Liabilities stood at $25.7 million in 2022, then sank by 75.5% to $6.3 million in 2023, then surged by 62.72% to $10.2 million in 2024, then increased by 23.93% to $12.7 million in 2025, then decreased by 7.94% to $11.7 million in 2026.
- Business Quant data shows TLPH's Total Liabilities at $11.7 million in Q1 2026, $12.7 million in Q4 2025, and $11.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Talphera | 89.88 Mn | 89.88 Mn | - | 12.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 11.68 Mn |
| Dec 31, 2025 | 12.68 Mn |
| Sep 30, 2025 | 11.57 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 9.40 Mn |
| Dec 31, 2024 | 10.24 Mn |
| Sep 30, 2024 | 11.37 Mn |
| Jun 30, 2024 | 12.13 Mn |
| Mar 31, 2024 | 12.44 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 7.31 Mn |
| Mar 31, 2023 | 12.05 Mn |
| Dec 31, 2022 | 25.67 Mn |
| Sep 30, 2022 | 20.77 Mn |
| Jun 30, 2022 | 22.99 Mn |
| Mar 31, 2022 | 110.24 Mn |
| Dec 31, 2021 | 113.79 Mn |
| Sep 30, 2021 | 115.28 Mn |